S. Y. Kim, C. Mocanu, D. S. Mcleod, I. A. Bhutto, C. Merges et al., Expression of pigment epithelium-derived factor 173 (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid, Exp Eye Res, vol.77, issue.4, pp.433-174, 2003.

, National Heart and Blood Institute Division of Blood Diseases and Resources. The management of sickle cell disease, Manag Sick cell Dis, vol.176, pp.95-102, 2002.

M. Elagouz, S. Jyothi, B. Gupta, and S. Sivaprasad, Sickle cell disease and the eye: Old and new concepts, Surv Ophthalmol, vol.178, issue.4, pp.359-77, 2010.

G. K. Asdourian, K. C. Nagpal, B. Busse, M. Goldbaum, D. Patriankos et al., Macular and perimacular vascular 180 remodelling sickling haemoglobinopathies, Br J Ophthalmol, vol.60, issue.6, pp.431-53, 1976.

C. Lemaire, Y. Lamarre, N. Lemonne, X. Waltz, S. Chahed et al., Severe proliferative retinopathy is associated 182 with blood hyperviscosity in sickle cell hemoglobin-C disease but not in sickle cell anemia, Clin Hemorheol Microcirc, vol.183, issue.2, pp.205-217, 2013.

B. E. Serjeant, K. P. Mason, P. I. Condon, R. J. Hayes, M. W. Kenny et al., Blood rheology and proliferative retinopathy 185 in sickle cell-haemoglobin C disease, Br J Ophthalmol, vol.68, issue.5, pp.325-333, 1984.

P. D. Fox, D. T. Dunn, J. S. Morris, and G. R. Serjeant, Risk factors for proliferative sickle retinopathy, Br J Ophthalmol, vol.187, issue.3, pp.172-178, 1990.

M. F. Goldberg, Classification and pathogenesis of proliferative sickle retinopathy, Am J Ophthalmol, vol.71, issue.3, pp.649-65, 1971.

R. J. Hayes, P. I. Condon, and G. R. Serjeant, Haematological factors associated with proliferative retinopathy in sickle cell190 haemoglobin C disease, Br J Ophthalmol, vol.65, issue.10, pp.712-719, 1981.

R. J. Hayes, P. I. Condon, and G. R. Serjeant, Haematological factors associated with proliferative retinopathy in homozygous 192 sickle cell disease, Br J Ophthalmol, vol.65, issue.1, pp.29-35, 1981.

I. C. Han, M. Tadarati, and A. W. Scott, Macular Vascular Abnormalities Identified by Optical Coherence Tomographic Angiog194 raphy in Patients With Sickle Cell Disease, JAMA Ophthalmol, vol.133, issue.11, pp.1337-1377, 2015.

R. Mathew, R. Bafiq, J. Ramu, P. E. Richardson, M. Drasar et al., Spectral domain optical coherence tomography 196 in patients with sickle cell disease, Br J Ophthalmol, vol.99, issue.7, pp.967-72, 2015.

R. K. Murthy, S. Grover, and K. V. Chalam, Temporal Macular Thinning on Spectral-Domain Optical Coherence Tomography 198 in Proliferative Sickle Cell Retinopathy, Arch Ophthalmol, vol.129, issue.2, p.247, 2011.

I. C. Han, M. Tadarati, K. D. Pacheco, and A. W. Scott, Evaluation of Macular Vascular Abnormalities Identified by Optical 200

, Coherence Tomography Angiography in Sickle Cell Disease, Am J Ophthalmol, vol.177, pp.90-99, 2017.

P. Connes, T. Alexy, J. Detterich, M. Romana, M. Hardy-dessources et al., The role of blood rheology in sickle 202 cell disease, Blood Rev, vol.30, issue.2, pp.111-119, 2016.

O. K. Baskurt, M. Boynard, G. C. Cokelet, P. Connes, B. M. Cooke et al., New guidelines for hemorheological 204 laboratory techniques, Clin Hemorheol Microcirc, vol.42, issue.2, pp.75-97, 2009.

A. S. Tan, T. C. Quah, P. S. Low, and S. S. Chong, A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for 206 alpha-thalassemia, Blood, vol.98, issue.1, pp.250-251, 2001.

J. Liu, X. Jia, N. Tang, X. Zhang, X. Wu et al., Novel technique for rapid detection of-globin gene mutations and 208 deletions, Transl Res, vol.155, issue.3, pp.148-55, 2010.

M. F. Goldberg, Retinal vaso-occlusion in sickling hemoglobinopathies, Birth Defects Orig Artic Ser, vol.12, issue.3, pp.210-475, 1976.

S. Chen, J. Hwang, and Y. Chen, Macular thickness measurements in central retinal artery occlusion by optical 212 coherence tomography, Retina, vol.31, issue.4, pp.730-737, 2011.